Bank Julius Baer & Co
WST icon

Bank Julius Baer & Co’s West Pharmaceutical WST Stock Holding History

Bank Julius Baer & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
7,276
+2,651
+57% +$810K 0.01% 308
2026
Q1 		$1.14M Sell
4,625
-3,795
-45% -$944K ﹤0.01% 371
2025
Q4 		$2.33M Sell
8,420
-3,072
-27% -$840K 0.01% 311
2025
Q3 		$3.01M Sell
11,492
-16,997
-60% -$4.13M 0.01% 285
2025
Q2 		$6.23M Sell
28,489
-6,093
-18% -$1.3M 0.02% 220
2025
Q1 		$7.69M Sell
34,582
-1,402
-4% -$386K 0.03% 211
2024
Q4 		$11.9M Buy
35,984
+4,483
+14% +$1.41M 0.04% 192
2024
Q3 		$9.59M Buy
+31,501
New +$9.65M 0.03% 191
2024
Q2 		– Sell
-19,623
Closed -$7.75M – 558
2024
Q1 		$7.75M Sell
19,623
-594
-3% -$220K 0.03% 183
2023
Q4 		$7.12M Buy
+20,217
New +$7.15M 0.03% 192
2023
Q2 		– Sell
-3,681
Closed -$1.27M – 610
2023
Q1 		$1.27M Sell
3,681
-1,368
-27% -$400K 0.01% 243
2022
Q4 		$1.19M Sell
5,049
-100
-2% -$23.7K 0.01% 243
2022
Q3 		$1.27M Buy
5,149
+642
+14% +$196K 0.01% 228
2022
Q2 		$1.36M Buy
4,507
+4,150
+1,162% +$1.35M 0.01% 242
2022
Q1 		$147K Hold
357
– – ﹤0.01% 456
2021
Q4 		$167K Sell
357
-110
-24% -$47.3K ﹤0.01% 550
2021
Q3 		$198K Sell
467
-73
-14% -$30.8K ﹤0.01% 542
2021
Q2 		$194K Sell
540
-1,561
-74% -$516K ﹤0.01% 564
2021
Q1 		$592K Buy
2,101
+1,289
+159% +$369K ﹤0.01% 419
2020
Q4 		$230K Sell
812
-45
-5% -$12.6K ﹤0.01% 547
2020
Q3 		$236K Sell
857
-35
-4% -$9.26K ﹤0.01% 482
2020
Q2 		$203K Buy
+892
New +$175K ﹤0.01% 450

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bank Julius Baer & Co's WST Position: Q2 2026 in Review

Bank Julius Baer & Co increased its West Pharmaceutical (WST) stake by 57% in Q2 2026, buying an estimated $810K and bringing the position to 7,276 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #308.

Bank Julius Baer & Co first reported a position in WST in Q2 2020 and has held it in 22 quarters since. The position peaked at $11.9M in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bank Julius Baer & Co held 7,276 shares of West Pharmaceutical worth $2.61M as of Q2 2026.
  • Bank Julius Baer & Co bought 2,651 West Pharmaceutical shares in Q2 2026, an estimated $810K.
  • West Pharmaceutical made up 0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #308 holding.
  • Bank Julius Baer & Co first reported a position in West Pharmaceutical in Q2 2020 and has held it in 22 quarters since.
  • Bank Julius Baer & Co's West Pharmaceutical position peaked at $11.9M in Q4 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.